-
EP4110386
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4110386
| EP4110386 - RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-COV-2 VIRUS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.12.2022 Database last updated on 06.11.2024 | |
| Former | The international publication has been made Status updated on 03.09.2021 | ||
| Former | unknown Status updated on 07.04.2021 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Tonix Pharma Limited No. 56 Fitzwilliam Square North Dublin 2, DO2 X224 / IE | For all designated states The Governors Of The University Of Alberta Suite 4000 10230 Jasper Avenue Edmonton, Alberta T5J 4P6 / CA | [2023/01] | Inventor(s) | 01 /
LEDERMAN, Seth 124 Mishaum Point Road South Dartmouth, MA 02748 / US | 02 /
GOEBEL, Scott, J. 7817 Worman's Mill Road Frederick, MD 21701 / US | 03 /
EVANS, David c/o University Of Alberta 6-020 Katz Group Centre Edmonton, AB T6G 2E1 / CA | 04 /
NOYCE, Ryan c/o University Of Alberta 6-020 Katz Group Centre Edmonton, AB T6G 2E1 / CA | [2023/01] | Representative(s) | Haley Guiliano International LLP 26-28 Bedford Row London WC1R 4HE / GB | [2023/01] | Application number, filing date | 21715007.7 | 26.02.2021 | [2023/01] | WO2021US20119 | Priority number, date | US202062981997P | 26.02.2020 Original published format: US 202062981997 P | US202063114514P | 16.11.2020 Original published format: US 202063114514 P | [2023/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021174142 | Date: | 02.09.2021 | Language: | EN | [2021/35] | Type: | A1 Application with search report | No.: | EP4110386 | Date: | 04.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.09.2021 takes the place of the publication of the European patent application. | [2023/01] | Search report(s) | International search report - published on: | EP | 02.09.2021 | Classification | IPC: | A61K39/215, C07K14/165, C12N15/863 | [2023/01] | CPC: |
A61K39/12 (EP,IL);
C12N15/86 (EP,IL,KR);
A61K39/215 (IL,KR,US);
A61P31/14 (EP,IL,KR);
C07K14/005 (EP,IL,KR);
C12N15/85 (IL,US);
C12N7/00 (IL,US);
A61K2039/5256 (IL,KR,US);
A61K2039/572 (IL,KR,US);
A61K2039/70 (IL,KR,US);
C12N2710/24043 (EP,IL);
C12N2710/24134 (IL,KR,US);
C12N2770/20022 (EP,IL,KR);
C12N2770/20034 (EP,IL,KR);
C12N2770/20071 (EP,IL,KR);
C12N2830/15 (EP,IL)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/01] | Title | German: | REKOMBINANTER POCKENVIRUS-IMPFSTOFF GEGEN DAS SARS-COV-2-VIRUS | [2023/01] | English: | RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-COV-2 VIRUS | [2023/01] | French: | VACCIN À BASE DE POXVIRUS RECOMBINANT CONTRE LE VIRUS SARS-COV-2 | [2023/01] | Entry into regional phase | 08.08.2022 | National basic fee paid | 08.08.2022 | Designation fee(s) paid | 08.08.2022 | Examination fee paid | Examination procedure | 08.08.2022 | Examination requested [2023/01] | 08.08.2022 | Date on which the examining division has become responsible | 14.04.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 30.01.2023 | Renewal fee patent year 03 | 29.01.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2005028634 (UNIV EMORY [US], et al) [I] 1-88 * claims 1-87 *; | [I]WO2005103259 (UNIV HEALTH NETWORK [CA], et al) [I] 1-88 * page 36 - page 39 *; | [I]WO2007093133 (CHINESE CT FOR DISEASE CONTROL [CN], et al) [I] 1-88 * paragraph [0032] *; | [I]EP3045181 (LUDWIG MAXIMILIANS UNIVERSITÄT MÜNCHEN [DE], et al) [I] 1-88 * paragraphs [0008] , [0 50] - paragraph [0055] *; | [IP] - MAITRA ARINDAM ET AL, "Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility", JOURNAL OF BIOSCIENCES, (20200604), vol. 45, no. 1, doi:10.1007/S12038-020-00046-1, ISSN 0250-5991, XP037368927 [IP] 1-88 * page 1 - page 18 * DOI: http://dx.doi.org/10.1007/s12038-020-00046-1 | [I] - CZUB M ET AL, "Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 17-18, ISSN 0264-410X, (20050318), pages 2273 - 2279, (20050318), XP027652161 [I] 1-88 * page 2273 - page 2279 * | [A] - GÓMEZ CARMEN E ET AL, "The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer", CURRENT GENE THERAPY, BENTHAM SCIENCE PUBLISHERS LTD, NL, (20080401), vol. 8, no. 2, ISSN 1566-5232, pages 97 - 120, XP009149369 [A] 1-88 * page 97 - page 120 * | by applicant | US2018251736 | WO2019213452 | - RALPH et al., J Infect Dev Ctries, (20200131), vol. 14, no. 1, pages 3 - 17 | - HIMLY et al., Virology, (19980000), vol. 248, pages 295 - 304 | - YAO XD et al., Journal of virology, (20030000), vol. 77, no. 13, pages 7281 - 90 | - RICE et al., Viruses, (20110300), vol. 3, no. 3, pages 217 - 232 | - SAM CKDUMBELL KR, "Expression of poxvirus DNA in coinfected cells and marker rescue of thermosensitive mutants by subgenomic fragments of DNA", Ann Virol, (19810000), vol. 132, pages 135 - 50 | - SCHEIFLINGER FDORNER FFALKNER FG, "Construction of chimeric vaccinia viruses by molecular cloning and packaging", Proceedings of the National Academy of Sciences of the United States of America, (19920000), vol. 89, no. 21, doi:10.1073/pnas.89.21.9977, pages 9977 - 81, XP000322463 DOI: http://dx.doi.org/10.1073/pnas.89.21.9977 | - "GenBank", Database accession no. MN908947.3 | - LEON et al., Vaccine, (20160000), vol. 34, pages 5878 - 5885 | - LOHR et al., Vaccine, (20090000), vol. 36, pages 4975 - 4982 | - OSBORNE JD et al., Vaccine, (20070000), vol. 25, no. 52, pages 8807 - 32 | - ROBERTS A et al., PLoS Pathog, (20070100), vol. 3, no. 1, page e5 | - KORBER et al., bioRxiv, (20200429), page 069054 | - PALLESEN et al., Proc Natl Acad Sci USA, (20170000), vol. 114, no. 35 | - EARL et al., Journal of Virology, (19900000), pages 2448 - 2451 | - CHAKRABARTI et al., BioTechniques, vol. 23, pages 1094 - 1097 | - DI PILATO et al., Journal of General Virology, (20150000), vol. 96, pages 2360 - 2371 | - KREMER M et al., Vaccinia virus and poxvirology, Humana Press, (20120000), vol. 890, pages 59 - 92 | - TULMAN ERDELHON GAFONSO CLLU ZZSAK LSANDYBAEV NT et al., "Genome of horsepox virus", Journal of virology, (20060000), vol. 80, no. 18, doi:10.1128/JVI.00945-06, pages 9244 - 58, XP055482189 DOI: http://dx.doi.org/10.1128/JVI.00945-06 | - YAO XD et al., Methods Mol Biol, (20040000), vol. 269, pages 51 - 64 | - YAO XDEVANS DH, Journal of Virology, (20030000), vol. 77, no. 13, pages 7281 - 90 | - EARL PL et al., J Virol, (19900500), vol. 64, no. 5, pages 2448 - 51 | - SUBBARAO, K et al., J. Virol., (20040000), vol. 78, pages 3572 - 3577 | - SADOFF, J et al., "Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blinded, randomized, placebo-controlled trial", MedRxiv, (20200000), pages 1 - 28 | - HARTMAN, A et al., "SARS-CoV-2 infection of African green monkeys result in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts", PLOS Pathogens, (20200000), vol. 16, no. 9, page el008903 | - JENNER, E., An Inquiry into the Causes and Effects of the Variolae Vaccinae, a Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire, and Known by the Name of The Cow Pox |